MGO One Seven’s Alder Biopharmaceuticals ALDR Stock Holding History

MGO One Seven’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22	Closed	–	–	1917
2018 Q4	$0	Buy	+22	New	+$282	﹤0.01%	1990
2018 Q1	$0	Hold	22	–	–	﹤0.01%	1948
2017 Q4	$0	Buy	+22	New	+$246	﹤0.01%	1843

Other funds holding ALDR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

MGO One Seven's ALDR Position: Q1 2019 in Review

MGO One Seven sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 22 shares.

MGO One Seven first reported a position in ALDR in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q4 2018. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

MGO One Seven reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 22 Alder Biopharmaceuticals shares in Q1 2019.
MGO One Seven first reported a position in Alder Biopharmaceuticals in Q4 2017 and held it in 3 quarters.
MGO One Seven's Alder Biopharmaceuticals position peaked at $0 in Q4 2018.
123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.